Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study

• Winfried M. Amoaku ,

  * E-mail: Winfried.Amoaku@nottingham.ac.uk

  Affiliation University of Nottingham, Academic Ophthalmology, Division of Clinical Neurosciences, and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

  ⨯
• Richard P. Gale,

  Affiliation York Teaching Hospital NHS Foundation Trust, York, United Kingdom

  ⨯
• Andrew J. Lotery,

  Affiliation Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  ⨯
• Geeta Menon,

  Affiliation Frimley Park Hospital NHS Foundation Trust, Frimley, United Kingdom

  ⨯
• Sobha Sivaprasad,

  Affiliation NIHR Moorfields Biomedical Research Centre, King’s College Hospital NHS Foundation Trust, London, United Kingdom

  ⨯
• Jennifer Petrillo,

  Current address: Biogen Idec, Global Market Access, Cambridge, MA, United States of America

  Affiliation Novartis Pharma AG, Basel, Switzerland

  ⨯
• Jennifer Quinn

  Current address: Otsuka Pharmaceutical Europe Ltd, Wexham, United Kingdom

  Affiliation Novartis Pharmaceuticals UK Limited, Frimley, United Kingdom

  ⨯